Mid Feb.
Announcement of
Annual Results
Mid to Late Feb.
Announcement of
4Q Results
/Corporate Presentation
(for institutional investors)
 
 
Mid May
Announcement of1Q Results
 
 
 
 
 
Mid Nov.
Announcement of 3Q Results
 
Jan.
Feb.
Mar.
Apr.
May.
Jun.
Jul.
Aug.
Sep.
Oct.
Nov.
Dec.
 
 
End of March
Annual General Meeting
Securities Report
 
 
 
 
Mid August
Announcement of 2Q Results
Mid to Late Aug.
Announcement of 3Q Results
(for institutional investors)
 
 
 
 

2025 Mar. 27

Annual General Meeting

2025 Feb. 20

Presentation of Financial Results for FY 2024

2025 Feb. 14

Announcement of Financial Results for FY 2024

Dec. 23

Briefing for Institutional Investors

Dec. 2

Briefing for individual investors

Nov. 14

Announcement of Financial Results for the 3rd Quarter of FY 2024

Oct. 21

Small meeting sponsored by Mizuho Securities

Aug. 27

Seminar sponsored by Domestic Securities “Fibrotic Drug Market in China”

Aug. 22

Presentation of Financial Results for the 2nd Quarter of FY 2024

Aug. 14

Announcement of Financial Results for the 2nd Quarter of FY 2024

May. 15

Announcement of Financial Results for the 1st Quarter of FY 2024